Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion. J Natl Cancer Inst. 1994 Mar 02; 86(5):368-72.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Benzofurans
Cyclohexanecarboxylic Acids
Cyclohexenes
Drug Administration Schedule
Female
Hematologic Diseases
Humans
Indoles
Infusions, Intravenous
Male
Middle Aged
Neoplasms
Treatment Outcome
authors with profiles
Mark J. Ratain
Richard Schilsky
Philip Charles Hoffman
Gini Fleming